Fmoc-L-MeAsp(tBu)-OH is an Fmoc-protected, side-chain modified amino acid derivative based on L-methionine-? (MeAsp) with a tert-butyl-protected side-chain carboxylate, forming a protected amino acid suitable for peptide chemistry. The molecule contains a free amino group masked by the Fmoc carbamate on the alpha-amine, a carboxylic acid at the alpha position, and a tert-butyl ester on the side-chain carboxyl functionality, with stereochemistry indicated as L in the product name. In synthesis, the orthogonal protection pattern supports stepwise assembly of peptides or peptide fragments on solid or solution-phase platforms while providing a controlled handle for side-chain deprotection and incorporation of the modified Asp residue into structure-activity or chemical biology studies.
CAT No: CP25391
CAS No:152548-66-8
Synonyms/Alias:Fmoc-N-Me-Asp(OtBu)-OH;152548-66-8;Fmoc-MeAsp(OtBu)-OH;fmoc-n-methyl-l-aspartic acid 4-tert-butyl ester;MFCD00237027;(2S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid;N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-aspartic acid beta-t-butyl ester;Fmoc-N-methyl-L-aspartic acid b-tert-butyl ester;Fmoc-L-MeAsp(tBu)-OH;(2S)-4-(tert-butoxy)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-4-oxobutanoic acid;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-(tert-butoxy)-4-oxobutanoic acid;N-Fmoc-N-methyl-L-aspartic Acid 4-tert-Butyl Ester;Fmoc-L-MeAsp(OtBu)-OH;Fmoc-N-Me-L-Asp(OtBu)-OH;Fmoc-Nalpha-methyl-L-aspartic acid beta-t-butyl ester;SCHEMBL1759730;CYWWLVIEAOUXGW-FQEVSTJZSA-N;N-alpha-Fmoc-N-alpha-methyl-L-aspartic acid beta-t-butyl ester;Fmoc-N-Me-Asp(OtBu)-OH, 97%;AKOS015895306;CS-W014456;FF48597;HY-W013740;AC-31987;DS-13719;F12339;Fmoc-Nalpha-methyl-L-aspartic acid beta-t-butylester;(S)-2-[(9H-fluoren-9-ylmethoxycarbonyl)-methyl-amino]-succinic acid 4-tert-butyl ester;(2S)-2-(9H-fluoren-9-ylmethoxycarbonyl-methylamino)-4-[(2-methylpropan-2-yl)oxy]-4-oxobutanoic acid;(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-tert-butoxy-4-oxobutanoic acid;802-787-3;
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-L-aspartic acid beta-t-butyl ester
Fmoc-L-MeAsp(tBu)-OH is an Fmoc-protected, stereodefined methionine-derived aspartic acid analog in which the side-chain carboxyl group is masked as a tert-butyl ester and the alpha-amino functionality is protected as an Fmoc carbamate. The molecule contains a single stereogenic center at the L-alpha position, a protected amine suitable for base-mediated peptide assembly, and an additional carboxyl functionality that can be revealed after tert-butyl deprotection. The Fmoc group provides orthogonal protection relative to acid-labile tert-butyl esters, enabling controlled exposure of the amino and side-chain carboxyl groups during stepwise synthesis. The resulting protected amino acid derivative functions as a chiral building block for peptide coupling and as a downstream intermediate for aspartate-containing motifs and functionalized side-chain carboxyl chemistry.
1. Peptide Synthesis
Fmoc-L-MeAsp(tBu)-OH is used in peptide synthesis workflows to construct aspartate-containing sequences with orthogonally protected functional groups. The Fmoc carbamate on the alpha-amine supports standard peptide coupling chemistry after base-triggered Fmoc removal, while the side-chain tert-butyl ester protects the aspartate carboxyl from premature acylation or side reactions. The defined L-configuration at the alpha-carbon supports stereochemically consistent incorporation into growing peptide chains, including sequences where aspartate side-chain participation is required for binding or catalysis. The protected amino acid derivative can be employed to prepare peptide building blocks for solid-phase or solution-phase assembly and to generate aspartate motifs after sequential deprotection.
2. Protected Amino Acid Chemistry
Fmoc-L-MeAsp(tBu)-OH serves as a protected amino acid synthesis intermediate for preparing carboxyl-functionalized derivatives with controlled protection-state management. The combination of an acid-labile tert-butyl ester and an Fmoc-protected amine enables orthogonal deprotection strategies that expose either the side-chain carboxyl or the free amine at targeted stages of a synthetic sequence. The presence of both protected and latent functional groups supports downstream transformations such as side-chain activation for amide formation, ester exchange, or conversion into protected aspartate derivatives for further elaboration. The chiral amino acid intermediate nature of Fmoc-L-MeAsp(tBu)-OH also makes it suitable for manufacturing route design where protection group compatibility and predictable deprotection behavior are required.
3. Peptidomimetics And SAR Studies
Fmoc-L-MeAsp(tBu)-OH can be applied in peptidomimetic construction and structure-activity relationship studies where aspartate side-chain geometry and carboxyl availability influence molecular recognition. The protected side-chain carboxyl enables incorporation into analog libraries without uncontrolled cross-linking during synthesis, while later deprotection can provide a handle for salt formation, hydrogen-bonding pattern tuning, or conjugation-ready functionality. The Fmoc-protected alpha-amine supports coupling into non-natural peptide scaffolds, including constrained or modified backbones that retain stereochemical fidelity at the L-alpha center. The resulting aspartate-bearing analogs can be used to generate structure-defined series for SAR investigations and for mapping how side-chain carboxyl presentation affects binding interactions.
4. Chemical Biology Conjugation
Fmoc-L-MeAsp(tBu)-OH supports chemical biology research and bioconjugation chemistry through controlled introduction of an aspartate side-chain carboxyl group into peptide-based probes. The tert-butyl-protected carboxyl can be preserved during assembly of labeled or targeting peptides, then deprotected to provide a reactive acidic functional group for subsequent coupling strategies such as amide bond formation or linker attachment. The Fmoc group enables sequential build-up of conjugate-ready constructs while minimizing undesired side reactions involving the amino functionality. The stereodefined, side-chain-functionalized peptide building block can be incorporated into affinity reagents, enzyme substrate analogs, or detection probes where carboxyl-mediated interactions and linker orientation are relevant.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-L-MeAsp(tBu)-OH is suitable for pharmaceutical manufacturing-oriented fine chemical synthesis where protected amino acid building blocks are required for reproducible peptide intermediate preparation. The orthogonal protection pattern, with Fmoc on the alpha-amine and tert-butyl on the side-chain carboxyl, supports scalable synthesis of aspartate-containing intermediates that can be carried through controlled deprotection and coupling steps. The defined stereochemistry helps maintain consistency across manufacturing batches by ensuring the intended L-configuration at the incorporation site. The protected amino acid derivative can be utilized to prepare peptide fragments and aspartate-rich intermediates that feed into downstream drug substance or drug product-related peptide construction processes.
6. Analytical Research Standards
Fmoc-L-MeAsp(tBu)-OH can be employed in analytical research as a stereochemically defined reference material for method development and characterization of aspartate-containing peptide products. The presence of both Fmoc and tert-butyl-protected functionalities provides characteristic mass and fragmentation behavior that can support LC-MS or MS/MS identification of protected intermediates and deprotected aspartate species. The compound's defined L-configuration and protected side-chain carboxyl state enable unambiguous tracking of synthesis steps, including monitoring of Fmoc removal and tert-butyl ester deprotection endpoints. The amino acid-based intermediate can also serve as a calibration or verification standard when assessing peptide coupling outcomes and protecting-group integrity in peptide chemistry workflows.
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.